Featured Archives - Page 24 of 32 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

Neurable Shifts to Licensing Model to Expand Brain-Computer Interface Technology

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

Bicycle Therapeutics Reports Promising Cancer Drug Data at AACR Meeting

Most Read

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Neurable Shifts to Licensing Model to Expand Brain-Computer Interface Technology

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

POPULAR CATEGORY

ABOUT US

FOLLOW US